AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31355944
Drug: Melatonin 25
RxNorm normalized name: calcium phosphate/melatonin 250 mg-1.5 mg ORAL TABLET,CHEWABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 25 mg administered for twelve weeks
Trial: 18024869
Drug: Four additional
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four additional cycles of third-generation, platinum-doublet treatment (arm A)
Trial: 18024869
Drug: Two additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two additional cycles of third-generation, platinum-doublet treatment (arm B)
Trial: 16209966
Drug: Enalapril (2.5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (2.5-10 mg)
Trial: 16209966
Drug: Losartan (25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (25-50 mg)
Trial: 12585142
Drug: Xiaoyu Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xiaoyu Tablet (XYT)
Trial: 12585142
Drug: Gastrodine lipid-lowering
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrodine lipid-lowering tablet
Trial: 7862416
Drug: Balanced Salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced Salt Solution (BSS) Plus
Trial: 7862416
Drug: Dextrose bicarbonate
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrose bicarbonate lactated Ringer's solution
Trial: 1772464
Drug: Hydrotalcite (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrotalcite (2 tablets qid, neutralizing capacity 122 mmol)
Trial: 31604061
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of hyaluronic acid (8 mL, range 4 to 11 mL)
Trial: 31604061
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of hyaluronic acid
Trial: 27684740
Drug: Extended flexible
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended flexible regimen of 20 μg ethinylestradiol and 3 mg drospirenone (EE/DRSPe.flex)
Trial: 27684740
Drug: 24/4 cyclical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24/4 cyclical regimen of the same formulation (EE/DRSP24/4)
Trial: 25711648
Drug: General psychiatric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General psychiatric management (10-session treatment)
Trial: 19808441
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics (1 g of cefazolin administered intravenously before the procedure)
Trial: 19808441
Drug: Placebo (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (no antibiotics administered)
Trial: 14971661
Drug: Insoluble nickel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insoluble nickel compounds (Ni3S2, NiS, HT NiO, LT NiO)
Trial: 18343244
Drug: Diclofenac 50
RxNorm normalized name: DICLOFENAC 50MG/MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 50 mg TID
Trial: 9448064
Drug: Sodium dichloroacetate
RxNorm normalized name: sodium dichloroacetate
DrugBank: Sodium dichloroacetate (DB16929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium dichloroacetate (DCA) administered to healthy volunteers, specific dosage not mentioned.
Trial: 8180032
Drug: Granisetron (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (any dose) with rescue doses
Trial: 8180032
Drug: Granisetron alone
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron alone (any dose)
Trial: 3358901
Drug: Nifedipine 20
RxNorm normalized name: nifedipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 20 mg 12 hourly
Trial: 3358901
Drug: Verapamil 80
RxNorm normalized name: verapamil 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 80 mg 8 hourly
Trial: 29216020
Drug: LP-pHF (1.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LP-pHF (1.9 g protein/100 kcal)
Trial: 29216020
Drug: Regular protein
RxNorm normalized name: PROTEIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular protein eHF (2.3 g protein/100 kcal)
Trial: 28044986
Drug: 24-month dual
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 24-month dual antiplatelet therapy (DAPT)
Trial: 22578254
Drug: Psilocybin (215
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psilocybin (215 μg/kg)
Trial: 22578254
Drug: Ketanserin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (50 mg)
Trial: 21131461
Drug: 4% lidocaine
RxNorm normalized name: Lidocaine 344 mg TOPICAL PATCH [Pain Relief 4% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% lidocaine topical anesthetic cream applied to the face for one hour without occlusion (Group A)
Trial: 21131461
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of 4% lidocaine applied to the face for one half-hour without occlusion (Group B)
Trial: 21131461
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of 4% lidocaine applied to the face for one hour without occlusion (Group C)
Trial: 21131461
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of 4% lidocaine applied to the face for one hour with occlusion (Group D)
Trial: 16361531
Drug: FEC50 plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEC50 plus tamoxifen (fluorouracil 500 mg/m2, epirubicin 50 mg/m2, cyclophosphamide 500 mg/m2, six cycles every 21 days)
Trial: 16361531
Drug: Tamoxifen alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen alone (30 mg/day, 3 years)
Trial: 9272481
Drug: Ketamine (subanesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (subanesthetic doses)
Trial: 6347755
Drug: Flurbiprofen (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen (100 mg three times a day)
Trial: 6347755
Drug: Paracetamol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (1 g three times a day)
Trial: 4009965
Drug: slow-release nifedipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: slow-release nifedipine (20 mg twice daily)
Trial: 30032885
Drug: Ketamine 0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0 mg kg‐1
Trial: 30032885
Drug: Ketamine 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.25 mg kg‐1
Trial: 30032885
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg kg‐1
Trial: 30032885
Drug: Ketamine 1
RxNorm normalized name: ketamine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 1 mg kg‐1
Trial: 26867863
Drug: Real-time medication
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Real-time medication monitoring (medication dispenser for ribavirin intake)
Trial: 26867863
Drug: Real-time medication
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Real-time medication monitoring
Trial: 26867863
Drug: Real-time medication
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Real-time medication monitoring and standard-of-care
Trial: 22729797
Drug: Cognitively oriented
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitively oriented behavioural rehabilitation in combination with Qigong
Trial: 15705369
Drug: GnRH-antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH-antagonist
Trial: 10596247
Drug: Ego‐Oriented Individual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ego‐Oriented Individual Therapy (EOIT)
Trial: 8695600
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch from potato (17-30 g/d)
Trial: 8695600
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch from banana (17-30 g/d)
Trial: 8695600
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch from wheat (17-30 g/d)
Trial: 8695600
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch from maize (17-30 g/d)
Trial: 8695600
Drug: Bran NSP
RxNorm normalized name: bran
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bran NSP (18.4 g NSP from bran/d)
Trial: 1917046
Drug: Intravenous penicillin
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous penicillin G sodium (PG) 400,000‐500,000 I.U./kg/day for 14 days
Trial: 1917046
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone 75‐93 mg/kg/day for 14 days
Trial: 6627213
Drug: Crossover therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crossover therapy (Adriamycin)
Trial: 29920736
Drug: Mirogabalin 15
RxNorm normalized name: mirogabalin
DrugBank: Mirogabalin (DB11825)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Mirogabalin 15 mg + Probenecid 500 mg every 6 h from days 1 to 4
Trial: 29920736
Drug: Mirogabalin 15
RxNorm normalized name: mirogabalin
DrugBank: Mirogabalin (DB11825)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Mirogabalin 15 mg + Cimetidine 400 mg every 6 h from days 1 to 4
Trial: 29920736
Drug: Mirogabalin 15
RxNorm normalized name: mirogabalin
DrugBank: Mirogabalin (DB11825)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Mirogabalin 15 mg alone
Trial: 27422406
Drug: CFNB/SAMO group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CFNB/SAMO group (continuous femoral nerve block with mini-dose spinal morphine)
Trial: 24814858
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5mg daily) and vitamin B12 (500 μg twice daily) for 12 weeks
Trial: 22574583
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine treatment group (Chinese medicine placebo, Western medicine, and rehabilitation)
Trial: 22574583
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Chinese medicine placebo and rehabilitation)
Trial: 21344827
Drug: Oral-B Pulsonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-B Pulsonic sonic toothbrush
Trial: 11777104
Drug: All conditions
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All conditions (High-standardization CBT, Low-standardization CBT, Treatment as usual)
Trial: 9610341
Drug: Iloprost low
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloprost low dose (LD) 100 micrograms bid for 8 weeks
Trial: 9610341
Drug: Iloprost high
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloprost high dose (HD) 200 micrograms bid for 8 weeks
Trial: 9610341
Drug: Iloprost low
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloprost low dose (LD) and high dose (HD)
Trial: 7923253
Drug: rt-PA administered
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rt-PA administered within 6 to 24 hours after onset of symptoms
Trial: 7923253
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no thrombolytic agent)
Trial: 3288479
Drug: Low-dose bromocriptine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose bromocriptine
Trial: 4627050
Drug: Continuous intragastric
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intragastric milk feeds (60 ml/kg/24 hr to 300 ml/kg/24 hr over 9 days) using either expressed human breast milk or SMA-S26.
Trial: 4627050
Drug: Half-cream Regal
RxNorm normalized name: Consolida regalis flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-cream Regal milk (partly-skimmed evaporated cows' milk)
Trial: 23019303
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (TU) 1000 mg i.m. injection followed by 500 mg injection every 6 weeks
Trial: 23019303
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate (TU) + levonorgestrel (LNG) 250 μg orally daily
Trial: 23019303
Drug: Testosterone treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone treatment in cynomolgus monkeys
Trial: 15961567
Drug: Early headgear
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early headgear (HG) treatment
Trial: 17349681
Drug: Fluticasone (88
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone (88 microg, 2 puffs twice daily)
Trial: 15072107
Drug: Carbamazepine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (600 mg/day)
Trial: 15072107
Drug: Valproate (1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valproate (1250 mg/day)
Trial: 11511432
Drug: Tezosentan (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tezosentan (5, 20, 50, 100 mg h(−1))
Trial: 9062499
Drug: Once weekly
RxNorm normalized name: Actonel 35 4-Week Once Weekly Dosepack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once weekly T4 therapy (7 times the normal daily dose)
Trial: 3518556
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg aerosolized verapamil
Trial: 3518556
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg aerosolized verapamil
Trial: 27567447
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of stimulant medication
Trial: 25176015
Drug: LCZ696 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCZ696 (200 mg twice daily)
Trial: 20695686
Drug: Oral caffeine
RxNorm normalized name: caffeine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral caffeine (250 mg/70 kg)
Trial: 17968001
Drug: 1 drug
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 drug administered at bedtime
Trial: 17968001
Drug: All drugs
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All drugs taken on awakening
Trial: 16970086
Drug: Fuzheng Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fuzheng Capsule (FC) and Quxie Capsule (QC)
Trial: 12936975
Drug: Single doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single doses of posaconazole oral tablets (50 to 1200 mg)
Trial: 12936975
Drug: Posaconazole oral
RxNorm normalized name: posaconazole Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posaconazole oral tablets (50 to 400 mg) twice daily for 14 days
Trial: 12936975
Drug: Posaconazole (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posaconazole (all doses)
Trial: 3555042
Drug: Cefotaxime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime (2 g three times daily)
Trial: 29406427
Drug: AR-L (aerobic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AR-L (aerobic before low-intensity resistance training)
Trial: 29406427
Drug: RA-L (aerobic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA-L (aerobic after low-intensity resistance training)
Trial: 19574172
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 500 mg twice daily for 3 months
Trial: 9449270
Drug: grepafloxacin 400
RxNorm normalized name: grepafloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: grepafloxacin 400 mg once daily
Trial: 9449270
Drug: grepafloxacin 600
RxNorm normalized name: grepafloxacin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: grepafloxacin 600 mg once daily
Trial: 28988687
Drug: Orantinib (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orantinib (200 mg, twice per day)
Trial: 26646462
Drug: Goal-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed therapy group (n = 62)
Trial: 26646462
Drug: Goal-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed therapy (meta-analysis)
Trial: 25937837
Drug: 8.0 mg
RxNorm normalized name: KAOLIN 8.0 mg in 100 mL ORAL LIQUID [Diarrhea Control]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8.0 mg oral melatonin nightly for 10 weeks
Trial: 20124733
Drug: SCH530348 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH530348 (20 or 40 mg loading dose followed by 1 mg/d or 2.5 mg/d for 60 days)
Trial: 20124733
Drug: Standard-of-care (aspirin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-of-care (aspirin, ticlopidine, and heparin)
Trial: 19035150
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy (blood glucose control at 4.4 to 6.1 mmol/L)
Trial: 19035150
Drug: Conventional group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional group (blood glucose control at 10.0 to 11.1 mmol/L)
Trial: 17235728
Drug: ACE chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE chemotherapy (doxorubicin 40 mg/m², cyclophosphamide 1000 mg/m², etoposide 120 mg/m² on day 1 IV, plus oral etoposide 240 mg/m² daily on days 2-3) with pegfilgrastim 6 mg by subcutaneous injection on day 4 of each cycle
Trial: 8851907
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (BIC) 0.3 g.kg body mass‐1
Trial: 8851907
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate (CIT) 0.5 g.kg body mass‐1
Trial: 8851907
Drug: Placebo (PLC,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PLC, wheat flour, 0.5 g.kg body mass‐1)
Trial: 30580266
Drug: goserelin 3.6 mg/28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: goserelin 3.6 mg/28 days by subcutaneous injection plus oral anastrozole 1 mg/day for 12 weeks
Trial: 30580266
Drug: oral tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral tamoxifen 20 mg/day for 12 weeks
Trial: 25175762
Drug: Purple grape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purple grape juice (pGJ), 6 ounces twice daily for 4 weeks
Trial: 25175762
Drug: Clear apple
RxNorm normalized name: Ensure Clear Apple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clear apple juice (cAJ), 6 ounces twice daily for 4 weeks
Trial: 20590748
Drug: Pioglitazone 30
RxNorm normalized name: pioglitazone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone 30 mg od for 12 weeks
Trial: 12088161
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg/day, increased to a maximum of 60 mg/day after week 2)
Trial: 10438710
Drug: Protocol II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol II (early reinduction treatment) for SRG patients
Trial: 10438710
Drug: No early
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No early reinduction treatment for SRG patients
Trial: 10438710
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment (DCLSG ALL-7)
Trial: 10438710
Drug: Overall CNS
RxNorm normalized name: CN-105
DrugBank: CN-105 (DB18345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall CNS prophylaxis (systemic high-dose methotrexate and intrathecal chemotherapy)
Trial: 2111126
Drug: Glucan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucan (50 mg/m2, intravenously daily for 7 days)
Trial: 2111126
Drug: Placebo (intravenously
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intravenously daily for 7 days)
Trial: 28786993
Drug: Uric acid
RxNorm normalized name: Uric acid
DrugBank: Uric acid (DB08844)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uric acid administration
Trial: 28786993
Drug: Rasburicase administration
RxNorm normalized name: Rasburicase
DrugBank: Rasburicase (DB00049)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rasburicase administration
Trial: 26536700
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of parecoxib sodium 40 mg after surgery, continued with 40 mg injections after 12, 24, and 36 hours.
Trial: 26536700
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg tramadol after surgery, replacing parecoxib sodium in group C.
Trial: 22859618
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (450 ml daily for 4 weeks)